BofA raised the firm’s price target on Eastman Chemical (EMN) to $79 from $74 and keeps a Buy rating on the shares. Despite a Q4 operating earnings miss and “soft” Q1 guidance, Eastman’s shares outperformed peers on Friday, which the firm views as driven by the perception that Eastman’s headwinds are cyclical, not structural and the appeal of its “decent balance sheet and free cash flow that can organically cover the dividend,” adding that it shares this view.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMN:
